Article
A comprehensive evaluation of CHEK2 germline mutations in men with prostate cancer
9 Mar 2018
Abstract excerpt
BACKGROUND: Germline mutations in CHEK2 have been associated with prostate cancer (PCa) risk. Our objective is to examine whether germline pathogenic CHEK2 mutations can differentiate risk of lethal from indolent PCa. METHODS: A case-case study of 703 lethal PCa patients and 1455 patients with low-risk localized PCa of European, African, and Chinese origin was performed. Germline DNA samples from these patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
